Log in
Local authorities, the UK government and the European Commission have benefitted from the widespread application of new molecular methodologies, developed in 2005 and applied by the University of Reading's Vertebrate Pests Unit (VPU) to identify and quantify anticoagulant rodenticide resistance in rodent populations. Rodents are a major global pest that consumes our food, causes contamination with urine and faeces, damages structures through gnawing, transmits diseases, and impacts on species of conservation concern. Due to historical success and recent regulatory restrictions, anticoagulant rodenticides are the most common control method for these pests. However, physiological resistance to anticoagulants is now widespread and the VPU has been involved in mapping this resistance and identifying the genetic basis for the resistance. Their research has led to new methodologies to identify anticoagulant resistance that have been adopted by the global plant science industry and to new guidance in treating resistant populations that has been adopted by the European biocides industry.
Professor Zoe Trodd has contributed to changes in antislavery policy debate and practice at local, national and international levels—from lawyers' societies and school teachers, to national non-governmental organisations (NGOs) and the European Parliament—through a series of publications, consultations, public talks, and contributions to teaching and digital resources about contemporary slavery and abolitionism. Drawing on her own research, as well as research into historic forms of slave resistance and literary abolitionism by two other professors in the UoA, she has intervened in contemporary abolitionism by advising the government bodies, NGOs and community organisations working to liberate slaves, pass antislavery legislation and remove slavery from industries' supply chains.
Based in the School of English, the Research and Development Unit for English Studies (RDUES) conducts research in the field of corpus linguistics and develops innovative software tools to allow a wide range of external audiences to locate, annotate and use electronic data more effectively. This case study details work carried out by the RDUES team (Matt Gee, Andrew Kehoe, Antoinette Renouf) in building large-scale corpora of web texts, from which examples of language use have been extracted, analysed, and presented in a form suitable for teaching and research across and beyond HE, including collaboration with commercial partners.
Research at the University of Exeter on the links between the Amazon rainforest and climate change has influenced international climate policy, has directly assisted Brazilian environmental policymakers, and has received international media coverage. The underpinning research spans the vulnerability of the rainforest to anthropogenic climate change and the mechanisms behind the Amazonian droughts of 2005 and 2010. Impact has been achieved by stimulating public debate through the media, by contribution to science-into-policy documents produced by the World Bank and for the United Nations Framework Convention on Climate Change (UNFCCC), and by direct face-to-face interaction with UK and Brazilian policymakers.
Research by Professor Joost de Bruijn and team at QMUL from 2004 was critical to demonstrating the efficacy and commercial viability of a novel Instructive Bone Graft (IBG) product, AttraXTM. The technology, commercialised via the spin-out business Progentix Orthobiology BV (founded in 2007) was sufficiently mature by 2008 to attract series A investment of €1 million series A financing by BioGeneration Ventures. The development of AttraXTM has led to a trade sale totalling up to US$ 80 million to the global top 5 spine company NuVasive Inc. in 2009. In 2011 an exclusive distribution deal with a global top 3 dental company was signed for use of the technology in the field of dentistry and craniomaxillofacial surgery. After regulatory approval of AttraXTM in Europe (CE mark), the product was commercialised in 2011 and has been used successfully in more than eleven thousand patients (as of 2013Q3) with global reach (including EU, US, Australia, New Zealand and Brazil). Within 1 year of commercialisation, a 1.1% share of the estimated US$2 billion global spinal bone graft market has been achieved. This research has seen an economical benefit in terms of newly formed jobs from 2 FTE in 2008 to 25 FTE in 2013 at Progentix Orthobiology BV.
Measurement of hormones is essential to the understanding and diagnosis of endocrine diseases. White and her research group have developed unique antibodies that are widely used in diagnostic assays for adrenocorticotrophic hormone (ACTH) and related peptides, including the first and only kit for measuring pro-opiomelanocortin (POMC), the precursor of ACTH. These assays are used worldwide for diagnosis, decisions on treatment, monitoring for recurrence of tumours and prognosis in a number of patient groups with life-threatening endocrine disorders. Global sales of the ACTH Elecsys tests by Roche exceeded 6 million kits since 2008. AstraZeneca has used the POMC and ACTH assays in its drug discovery programmes in the cardiovascular and metabolic diseases therapy area. The antibodies therefore have had health impact in relieving suffering and in improving patient care, as well as commercial impact in worldwide sales of assays and influencing drug development strategies.
Professor Peter Giblin (Department of Mathematical Sciences at the University of Liverpool), together with collaborators, used methods from singularity theory to develop an approach for recovering 3-d information from 2-d images, such as photos. In the past decade, these have been implemented and built upon by software engineers, leading to significant cultural, economic and societal impacts. These include the creation of an innovative 25m high sculpture of the human body in the Netherlands by the sculptor Antony Gormley and the virtual modelling of clothing on online clothing websites such as Tesco's (Virtual Changing Room by Tesco/F&F). These have reached thousands of consumers worldwide and represent a significant commercial success for the company which developed the software.
Since its discovery in the 1980s, avian metapneumovirus (AMPV) has spread in poultry populations worldwide with major adverse health and food security implications for commercial chickens and turkeys. Research at the University of Liverpool (UoL) led to the registration of a live vaccine in 1994 which has played a global role in AMPV control, thereby safeguarding the supply of poultry meat and eggs. Recent research and development at the UoL has identified key control measures, relating to vaccine application, vaccine selection, efficacy and safety, which have had a significant impact on poultry health and consequently, poultry producers and consumers. In particular, demonstration that live AMPV vaccines can revert to virulence, that vaccine type applied influences field protection and that continuous use of a single vaccine can influence circulating field strains, has resulted in UoL leading policy making with regard to current AMPV vaccine protocols.
Research at UCL pioneered B cell depletion to treat rheumatoid arthritis (RA) and also stimulated the development of B-cell-directed therapies for other autoimmune rheumatic, haematological and neurological diseases. Now NICE approved, B cell depletion (based on rituximab) in RA is as effective as the alternative (anti-TNFα drugs) and an option for patients unable to gain benefit from anti-TNFα drugs. Rituximab offers drug-cost savings of up to £5,000/annum/patient and for many is a more convenient therapy, being given as an infusion only every five months apart, or more. B cell depletion has also proved to have an excellent safety profile, with many receiving repeated courses of treatment. As a consequence of UCL research, rituximab has brought substantial benefit to patients with many autoimmune diseases, including over 200,000 who have been treated with rituximab for RA so far.
The project led to improved public access to partner collections via a major website, informed the design of the £10m HLF-funded Birmingham History Galleries of Birmingham Museum and Art Gallery (including innovative multi-touch software), and firmly embedded a culture of cross-sector collaboration with impact in Birmingham, the Midlands, and beyond.